Enhanced delivery of cell-penetrating peptide-peptide nucleic acid conjugates by endosomal disruption.
about
Correction of a splice-site mutation in the beta-globin gene stimulated by triplex-forming peptide nucleic acidsMechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides.Modulation of mdm2 pre-mRNA splicing by 9-aminoacridine-PNA (peptide nucleic acid) conjugates targeting intron-exon junctions.Photochemical internalization of tumor-targeted protein toxins.A preclinical study combining the DNA repair inhibitor Dbait with radiotherapy for the treatment of melanoma.Nanoparticles deliver triplex-forming PNAs for site-specific genomic recombination in CD34+ human hematopoietic progenitors.Targeted intracellular delivery of proteins with spatial and temporal control.A role for peptides in overcoming endosomal entrapment in siRNA delivery - A focus on melittinBax-derived membrane-active peptides act as potent and direct inducers of apoptosis in cancer cells.Delivery of cell-penetrating peptide-peptide nucleic acid conjugates by assembly on an oligonucleotide scaffoldGenomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleasesCationic shell-cross-linked knedel-like (cSCK) nanoparticles for highly efficient PNA delivery.Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment.Phospholipid conjugate for intracellular delivery of peptide nucleic acidsSite-specific Genome Editing in PBMCs With PLGA Nanoparticle-delivered PNAs Confers HIV-1 Resistance in Humanized Mice.Chemically modified cell-penetrating peptides for the delivery of nucleic acids.Intracellular transduction using cell-penetrating peptides.Polymer delivery systems for site-specific genome editingmiRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs.Canonical and non-canonical barriers facing antimiR cancer therapeuticsA peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcriptionRecognition of double-stranded RNA by guanidine-modified peptide nucleic acids.Quantitative fluorescence spectroscopy and flow cytometry analyses of cell-penetrating peptides internalization pathways: optimization, pitfalls, comparison with mass spectrometry quantificationElectroporation-based delivery of cell-penetrating peptide conjugates of peptide nucleic acids for antisense inhibition of intracellular bacteria.Intracellular delivery of peptide nucleic acid and organic molecules using zeolite-L nanocrystals.Characterization of the cell-penetrating properties of the Epstein-Barr virus ZEBRA trans-activatorReduction of doxorubicin resistance in P-glycoprotein overexpressing cells by hybrid cell-penetrating and drug-binding peptide.Glycosylated cell-penetrating peptides and their conjugates to a proapoptotic peptide: preparation by click chemistry and cell viability studies.Assessing the delivery efficacy and internalization route of cell-penetrating peptides.Evaluation of Cell Penetrating Peptide Delivery System on HPV16E7 Expression in Three Types of Cell LineCell number and transfection volume dependent peptide nucleic acid antisense activity by cationic delivery methodsRecent advances in chemical modification of Peptide nucleic acids.DNA nuclease activity of Rev-coupled transition metal chelates.Effective photo-enhancement of cellular activity of fluorophore-octaarginine antisense PNA conjugates correlates with singlet oxygen formation, endosomal escape and chromophore lipophilicity.Sequence-selective recognition of double-stranded RNA and enhanced cellular uptake of cationic nucleobase and backbone-modified peptide nucleic acids.Tat-tetanus toxin fragment C: a novel protein delivery vector and its use with photochemical internalization.Peptide Nucleic Acids as a Tool for Site-Specific Gene Editing.Bifunctional up-converting lanthanide nanoparticles for selective in vitro imaging and inhibition of cyclin D as anti-cancer agents
P2860
Q24652641-C166787D-1826-477F-8815-63D4D2CD9610Q33581506-19A4490A-2FD6-431B-AA82-9C5FA58FE9CEQ33621929-FC0E8097-5F79-4208-A6C5-4D70A8E02C37Q34068201-9E93AD5D-357F-45B5-B978-3B872266F196Q34417540-1CFAB9BD-0CBD-4C5F-8BC1-C3B70FC0513FQ34473283-2618DF2B-D9B2-4DD9-8FCF-69D8F86D7BE0Q35057544-4E23C89C-42BE-437C-ACA6-B0C35E640CD5Q35967737-DB6D5576-B803-4DBA-A460-3588E99093F3Q36191432-251D9DFE-DB06-4F0E-9B1D-F2EB1F80659FQ36324365-65916594-7073-45A1-A7E8-BE3DA95ED228Q36915157-5CB70EAB-894B-4628-9A04-33BC1436250BQ37236055-71D26421-5EAB-449D-8080-078B099911C3Q37347451-2276706A-9CBD-4945-8C68-CE17E5A89646Q37363141-0FC8878A-0781-4CD3-B4A0-465B1913C8B3Q37391145-88DAB446-399A-4713-A59A-C99EA58EE4EFQ37467837-91F8631E-EFA9-4FD1-8D9F-066F1B5702E4Q37615342-E432CAFD-4B1D-4FB3-B1FB-C084F7D86003Q37710990-34DB2F78-C61A-441C-88D6-DB37DB89C329Q37881210-86446F42-AFDE-40FA-BA29-E4A7B733139BQ37962609-A89E00B7-4920-4348-B0BD-052AA573C9F9Q38112723-97E7E192-A2AE-470B-9627-4649380897D7Q38324450-0255284B-C8A7-4940-9BAF-2BBF63C7E427Q38329694-393A243E-B6DD-4DA7-BF5A-41CA59A074C4Q38731173-DDFBABAA-5068-4CB8-8F70-D3DEEF79D9BCQ38962523-A0E8A0EB-E63C-4506-98BE-14FC7B5BD992Q38999400-F253B98D-C2D8-49CE-8107-6C679FC2C388Q39715723-756547D8-1B17-4D4F-A6C5-64A2466B84B5Q39750027-D8B7C5B3-B700-4BFA-BE64-9AAC69CFDAC7Q39973491-0C4D9E53-8EB3-466A-B79D-D72AF729C282Q40182984-9B3CFD4C-E002-4921-BD30-1BC393AE1B61Q41674446-1800C3B7-BD8C-42DE-8384-BCE78B6C387DQ42185605-DABB20C9-16CC-4D78-88F8-1F7A8A583685Q42325696-BAA57A0A-6FD0-4192-9714-544E6146051CQ46112289-B6C31FA9-FF78-4A85-A945-A8714A1EB1ABQ48251257-A118083F-E381-4B3F-94FC-56165F2C29B4Q50233498-019690D6-660E-4D20-9452-2B3C777686D4Q50970899-11BB3501-24D3-4673-9AFE-FD750011E8C6Q52657758-9E60DF99-036E-4C92-8CA4-AB1D66097A0AQ57696757-4058079A-6B98-4472-92AC-27246234024D
P2860
Enhanced delivery of cell-penetrating peptide-peptide nucleic acid conjugates by endosomal disruption.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Enhanced delivery of cell-pene ...... gates by endosomal disruption.
@en
type
label
Enhanced delivery of cell-pene ...... gates by endosomal disruption.
@en
prefLabel
Enhanced delivery of cell-pene ...... gates by endosomal disruption.
@en
P2860
P356
P1433
P1476
Enhanced delivery of cell-pene ...... gates by endosomal disruption.
@en
P2093
Peter E Nielsen
Takehiko Shiraishi
P2860
P2888
P304
P356
10.1038/NPROT.2006.92
P577
2006-01-01T00:00:00Z